Carcinoma, Ovarian Epithelial: all 1,619 studies

Page 5 of 17. Open to participants first (245), then studies with results posted, then the rest; newest registration first within each.

• Irinotecan and Bevacizumab for Recurrent Ovarian CancerCompletedNCT01091259Phase 2Results posted
• Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological MalignanciesCompletedNCT01079832Phase 2Results posted
• Ovarian Cancer Vaccine for Patients in RemissionCompletedNCT01068509Phase 2Results posted
• An Open Label Extension Study of the Efficacy of MORAb-003TerminatedNCT01018563Phase 2Results posted
• Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/CarboplatinCompletedNCT01012336Phase 2Results posted
• Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerCompletedNCT01010126Phase 2Results posted
• Topotecan With Erlotinib for Topotecan Pretreated Ovarian CancerTerminatedNCT01003938Phase 2Results posted
• Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian CancerCompletedNCT00993655Phase 2Results posted
• Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or CisplatinCompletedNCT00993616Phase 2Results posted
• Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian CancerCompletedNCT00979992Phase 2Results posted
• AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian CancerCompletedNCT00976911Phase 3Results posted
• Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility StudyTerminatedNCT00968799Not applicableResults posted
• Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity CancerStatus unknownNCT00954174Phase 3Results posted
• Combination Chemotherapy With CS-1008 to Treat Ovarian CancerCompletedNCT00945191Phase 2Results posted
• Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)CompletedNCT00945139Phase 2Results posted
• A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00939809Phase 2Results posted
• A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian CancerCompletedNCT00937560Phase 2Results posted
• ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian CancerTerminatedNCT00929162Phase 2Results posted
• Gleevec and Gemzar in Patients With Epithelial Ovarian CancerCompletedNCT00928642Phase 2Results posted
• Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian CancerTerminatedNCT00910000Phase 1/2Results posted
• A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian CancerCompletedNCT00880360Phase 2Results posted
• Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian CancerCompletedNCT00867503Phase 2Results posted
• Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD)TerminatedNCT00862836Phase 1/2Results posted
• OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete RemissionCompletedNCT00857545Phase 2Results posted
• Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer PatientsCompletedNCT00856791Phase 2Results posted
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First RelapseTerminatedNCT00849667Phase 3Results posted
• EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver MetastasesCompletedNCT00848510Phase 1Results posted
• Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian CancerCompletedNCT00826150Phase 1/2Results posted
• Tumor Gene Expression in Women With Ovarian CancerCompletedNCT00817479Phase 4Results posted
• Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian CancerCompletedNCT00806156Phase 2Results posted
• Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantCompletedNCT00795769Phase 2Results posted
• Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian CancerCompletedNCT00753545Phase 2Results posted
• Tranexamic Acid in Surgery of Advanced Ovarian CancerCompletedNCT00740116Phase 4Results posted
• A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete RemissionCompletedNCT00739661Phase 2Results posted
• An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian CancerTerminatedNCT00738699Phase 2Results posted
• A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)CompletedNCT00727961Phase 4Results posted
• Study of Ramucirumab in Ovarian CancerCompletedNCT00721162Phase 2Results posted
• Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or TopotecanTerminatedNCT00720096Not applicableResults posted
• Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian CancerTerminatedNCT00718523Phase 2Results posted
• Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian CancerCompletedNCT00702299Phase 1Results posted
• Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian CancerCompletedNCT00699907Phase 2Results posted
• Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal CancerTerminatedNCT00652899Phase 2Results posted
• Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian CancerCompletedNCT00628251Phase 2Results posted
• Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00616941Phase 1Results posted
• CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial CancerCompletedNCT00610740Phase 2Results posted
• AZD0530 Phase II Study in Patients With Advanced Ovarian CancerCompletedNCT00610714Phase 2Results posted
• A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian CancerTerminatedNCT00585052Phase 2Results posted
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer PatientsTerminatedNCT00583622Phase 2Results posted
• Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal CarcinomaTerminatedNCT00582205Phase 2Results posted
• Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)CompletedNCT00562640Phase 1Results posted
• Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological TumorsCompletedNCT00561795Phase 2Results posted
• Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00538031Phase 2Results posted
• Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian CancerTerminatedNCT00526799Phase 1/2Results posted
• Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second RemissionTerminatedNCT00522301Phase 2Results posted
• Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian CancerCompletedNCT00511992Phase 2Results posted
• Gleevec Study for Patients With Ovarian CancerCompletedNCT00510653Phase 2Results posted
• Chemoimmunotherapy Study for Patients With Epithelial Ovarian CancerCompletedNCT00501644Phase 2Results posted
• Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian CancerCompletedNCT00494442Phase 2Results posted
• Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian CancerCompletedNCT00477386Phase 1/2Results posted
• Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous ChemotherapyCompletedNCT00466960Phase 2Results posted
• Safety and Efficacy Study of Glufosfamide in Ovarian CancerTerminatedNCT00442598Phase 2Results posted
• VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00436501Phase 1/2Results posted
• Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00429793Phase 2Results posted
• A Study of Chemotherapy Treatment for Patients With Ovarian CancerCompletedNCT00428610Phase 2Results posted
• A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentCompletedNCT00421889Phase 1/2Results posted
• Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer PatientsTerminatedNCT00418574Phase 2/3Results posted
• Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantCompletedNCT00408681Not applicableResults posted
• Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian CancerCompletedNCT00408603Phase 2Results posted
• Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00408590Phase 1Results posted
• Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal CancerCompletedNCT00407563Phase 2Results posted
• Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")CompletedNCT00391118Phase 2Results posted
• Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian CancerCompletedNCT00390611Phase 2Results posted
• Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaCompletedNCT00390234Phase 2Results posted
• Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00388037Phase 2Results posted
• Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to ChemotherapyCompletedNCT00377429Phase 2Results posted
• Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerTerminatedNCT00373217Phase 2Results posted
• Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian CancerCompletedNCT00345540Phase 2Results posted
• Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn CancersCompletedNCT00343044Phase 2Results posted
• Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT00334893Phase 2Results posted
• Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian CancerCompletedNCT00327171Phase 2Results posted
• Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based ChemotherapyCompletedNCT00318370Phase 2Results posted
• Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian CancerCompletedNCT00316173Phase 2Results posted
• Oxaliplatin and Topotecan in Advance Ovarian CancerTerminatedNCT00313612Phase 2Results posted
• Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential TumorsCompletedNCT00301756Phase 2Results posted
• Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative MedicineCompletedNCT00293293Not applicableResults posted
• A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian CancerCompletedNCT00281632Phase 2Results posted
• Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT00278343Phase 2Results posted
• AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00275028Phase 2Results posted
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00262847Phase 3Results posted
• Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving TrastuzumabCompletedNCT00194714Phase 1/2Results posted
• Gemcitabine in Ovarian CancerCompletedNCT00191334Phase 2Results posted
• Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian CancerCompletedNCT00182767Phase 1/2Results posted
• Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian CancerCompletedNCT00170625Phase 1/2Results posted
• Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian CancerCompletedNCT00170573Phase 2Results posted
• Taxol Carboplatin and ErythropoetinCompletedNCT00158379Phase 2Results posted
• GM-CSF, Sargramostim in Women With Recurrent Ovarian CancerCompletedNCT00157573Phase 2Results posted
• Bevacizumab and Erlotinib Study in Advanced Ovarian CancerCompletedNCT00130520Phase 2Results posted
• Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)CompletedNCT00129727Phase 2Results posted
• An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian CancerCompletedNCT00113607Phase 3Results posted
• Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal CancerCompletedNCT00113373Phase 2Results posted

← Carcinoma, Ovarian Epithelial overview